AAV vector engineering for human aorta transduction: becoming a smooth operator.
Saved in:
| Title: | AAV vector engineering for human aorta transduction: becoming a smooth operator. |
|---|---|
| Authors: | Rapti K; Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120, Heidelberg, Germany., Grimm D; Department of Infectious Diseases/Virology, Section Viral Vector Technologies, Medical Faculty, Heidelberg University, BioQuant, Center for Integrative Infectious Diseases (CIID), 69120, Heidelberg, Germany. dirk.grimm@bioquant.uni-heidelberg.de.; German Center for Infection Research (DZIF) and German Center for Cardiovascular Research (DZHK), partner site Heidelberg, 69120, Heidelberg, Germany. dirk.grimm@bioquant.uni-heidelberg.de.; Faculty of Engineering Sciences, Heidelberg University, 69120, Heidelberg, Germany. dirk.grimm@bioquant.uni-heidelberg.de. |
| Source: | Gene therapy [Gene Ther] 2025 Jul; Vol. 32 (4), pp. 331-332. Date of Electronic Publication: 2025 Mar 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5462 (Electronic) Linking ISSN: 09697128 NLM ISO Abbreviation: Gene Ther Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
